Skip to navigation Skip to main content
Home
  • About us
    • Mission
    • Organization
      • Director
      • Management board
      • Scientific Council
      • Advisory Committee
    • 1H-TOXRUN Regulation
    • Support Offices
      • Bibliometric & Financing Office
      • Data Science Office
      • Communication and Public Engagement
    • Affiliated Journals
    • Collaborations
      • National collaborations
      • International collaborations
    • Reports
    • Contacts
    • People
    • Jobs & Opportunities
  • Research Labs of UCIBIO
    • Forensic Science Lab
    • Toxicologic Pathology Lab
    • Translational Toxicology Lab
  • Projects
  • Publications
    • All publications
    • Papers in scientific journals
    • Book and book chapters
    • Patents
  • Ethics & Integrity
    • TERIO
    • IUCS Ethics Committee
    • ORBEA
  • Training
    • Doctoral Programs
    • Master Degrees
    • Advanced courses
    • Events
      • Congresses
      • Seminars
      • Workshops
  • Facilities & Services
    • Laboratories
    • Equipments
    • Services
  • Media
    • News
    • Press
  • Science & Society

Search form

  • Breaking

    the boundaries between basic and clinical sciences

    Click here

  • Improving

    health with the power of the scientific discovery

    Click here

  • Investigating

    the causes, diagnosis, treatment and prevention of human diseases

    Click here

  • Serving

    the society. Sharing the knowledge

    Click here

Welcome to One Health Toxicology Research Unit

The R&D Unit of IUCS

 

SAVE THE DATE

Joint meeting.png

 

MORE INFORMATION

light-4297386_1920.jpg

Projects

newspaper-973049_1920 n.jpg

News

financial-2860753_1920.jpg

Publications

lABORATORIOS.jpg

Facilities & Services

 

TARGET4OC_GI2-CESPU-2025 - Targeting Resistant Ovarian Cancer: High-Throughput Screening for Personalized Treatments.

  • admin-cespu
  • January 13, 2026
  • 0 comment(s)
  • Read more about TARGET4OC_GI2-CESPU-2025 - Targeting Resistant Ovarian Cancer: High-Throughput Screening for Personalized Treatments.

RECAP-DCA_GI2-CESPU-2025 - Dichloroacetate-Induced Mitochondrial Reprogramming to Overcome Multidrug Resistance in Oral Cancer.

  • admin-cespu
  • January 13, 2026
  • 0 comment(s)
  • Read more about RECAP-DCA_GI2-CESPU-2025 - Dichloroacetate-Induced Mitochondrial Reprogramming to Overcome Multidrug Resistance in Oral Cancer.

PLASTICAR_GI2-CESPU-2025 - Validation of MET plasticity-induced drug resistance in pancreatic cancer.

  • admin-cespu
  • January 13, 2026
  • 0 comment(s)
  • Read more about PLASTICAR_GI2-CESPU-2025 - Validation of MET plasticity-induced drug resistance in pancreatic cancer.

Pages

  • « first
  • ‹ previous
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • next ›
  • last »

Contact info

E-mail: 1htoxrun@iucs.cespu.pt

Address: Avenida Central de Gandra, 1317

4585-116 Gandra PRD, Portugal

GPS:41.183509, -8.445928 | N 41° 11′ 0.6324″, W 8° 26′ 45.3408″

Telephone: +351 224 157 100/189/224 (chamada para rede fixa nacional)

1H-TOXRUN IUCS-CESPU in social media

Management institution

logo_iucs_cor.png

1H-TOXRUN © 2026 Política de privacidade e termos de uso